✦ LIBER ✦

Phase I and Pharmacokinetic Study of Fostriecin given as an Intravenous Bolus Daily for Five Consecutive Days

✍ Scribed by Lyly H. Lê; Charles Erlichman; Linda Pillon; Jake J. Thiessen; Andrew Day; Nancy Wainman; Elizabeth A. Eisenhauer; Malcolm J. Moore

Book ID: 111579895
Publisher: Springer US
Year: 2004
Tongue: English
Weight: 108 KB
Volume: 22
Category: Article
ISSN: 0167-6997
DOI: 10.1023/b:drug.0000011792.13160.b0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical trial of gemcitabine gi

Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days

✍ O'Rourke, T.J.; Brown, T.D.; Havlin, K.; Kuhn, J.G.; Craig, J.B.; Burris, H.A.; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Final results of a phase I and pharmacok

Final results of a phase I and pharmacokinetic study of γ-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors

✍ Mary Johansen; Thomas Zukowski; PauloM. Hoff; RobertA. Newman; Dan Ni; Toni Hutt 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 226 KB

A phase I study of ifosfamide with mesna

A phase I study of ifosfamide with mesna given daily for 3 consecutive days to children with malignant solid tumors

✍ Charles B. Pratt; William H. Meyer; Edwin C. Douglass; Laura Bowman; Judith Wili 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB 👁 2 views

Phase I and pharmacologic study of diflo

Phase I and pharmacologic study of diflomotecan (BN80915) administered intravenously daily for 5 consecutive days every 3 weeks in patients with solid tumors

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB

A phase I study of BAY 38-3441 given as

A phase I study of BAY 38-3441 given as a short infusion daily for five days every 3 weeks. a National Cancer Institute of Canada Clinical Trials Group Study

✍ L. Seymour; L. Siu; G. Batist; J. Cammisano; M. Maclean; L. McIntosh; O. Petrenc 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 189 KB